ADD CONDITION

items per page

Gold Bond Maximum Strength Foot Pain Relief

Last content change checked dailysee data sync status

Active ingredient
Lidocaine Hydrochloride 4 g/100 g
Other brand names
Drug classes
Amide Local Anesthetic, Antiarrhythmic
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2026
Label revision date
March 1, 2026
Active ingredient
Lidocaine Hydrochloride 4 g/100 g
Other brand names
Drug classes
Amide Local Anesthetic, Antiarrhythmic
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2026
Label revision date
March 1, 2026
Manufacturer
Gold Bond Co LLC
Registration number
M017
NDC root
84714-0427

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Gold Bond Maximum Strength Foot Pain Relief Cream is a topical cream designed to temporarily relieve minor pain in your feet. This product can be particularly helpful if you're experiencing discomfort from conditions like sore muscles or minor aches. With a convenient size of 1.75 oz (49g), it's easy to apply and can be a supportive option for managing foot pain.

Uses

You can use this medication to temporarily relieve minor pain. Whether you're dealing with a headache, muscle ache, or other types of discomfort, it can help ease your symptoms for a short period. Always remember to follow the recommended guidelines for use to ensure safety and effectiveness.

Dosage and Administration

For adults and children over 12 years old, you should apply a thin layer of the medication to the affected area every 6 to 8 hours. However, make sure not to exceed three applications within a 24-hour period. After applying, gently massage the medication into the painful area until it is fully absorbed into your skin.

If you are considering this medication for a child under 12 years of age, it’s important to consult a doctor first to ensure it’s safe and appropriate for them.

What to Avoid

You should avoid using this product if you have serious foot problems, such as ulcers or infections, or if you experience numbness or a reduced ability to feel pain. It's also important not to apply it to cut, irritated, or swollen skin, or on puncture wounds. If you need to use it for more than one week, please consult your doctor first.

While using this product, make sure to keep it away from your eyes and mucous membranes. Avoid tightly bandaging the area or applying local heat, such as heating pads, and do not use it alongside other topical pain relievers. Your safety is important, so please follow these guidelines carefully.

Side Effects

When using this product, it's important to be aware of potential side effects and warnings. You should not use it if you have serious foot problems like ulcers or infections, numbness, or reduced ability to feel pain. Avoid applying it to cut, irritated, or swollen skin, and do not use it on puncture wounds or for more than a week without consulting a doctor.

If you notice any worsening of your condition, redness, or irritation, or if symptoms persist for more than seven days or return shortly after improvement, stop using the product and consult a doctor. Additionally, if you are pregnant or breastfeeding, it's best to seek advice from a healthcare professional before use. Always keep this product out of reach of children, and if swallowed, seek medical help immediately.

Warnings and Precautions

This product is intended for external use only. You should not use it if you have serious foot problems, such as ulcers or infections, or if you experience numbness or a reduced ability to feel pain. Avoid applying it to cut, irritated, or swollen skin, as well as on puncture wounds. Additionally, do not use it for more than one week without consulting your doctor.

If your condition worsens, if you notice redness or irritation, or if your symptoms persist for more than seven days or return shortly after improvement, stop using the product and contact your doctor.

In case of accidental swallowing, seek emergency medical help or contact a Poison Control Center immediately.

Overdose

If you or someone else has swallowed a medication and you suspect an overdose, it’s important to act quickly. You should seek medical help or contact a Poison Control Center right away. Signs of an overdose can vary, but they may include unusual drowsiness, confusion, or difficulty breathing.

Remember, it’s always better to be safe and get professional advice if you think an overdose has occurred. Don’t hesitate to reach out for help.

Pregnancy Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using this medication. They can provide guidance on whether it’s safe for you and your baby. Always prioritize your health and the health of your child by seeking expert advice.

Lactation Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using any medication. This ensures that you understand any potential risks and can make informed decisions about your health and the health of your baby. Always prioritize open communication with your doctor regarding your breastfeeding journey.

Pediatric Use

If your child is under 12 years old, it's important to consult a doctor before using this medication. For those aged 12 and older, you can apply a thin layer to the affected area every 6 to 8 hours, but be sure not to exceed three applications in a 24-hour period. Gently massage the medication into the skin until it is fully absorbed. Always follow these guidelines to ensure safe and effective use.

Geriatric Use

While there is no specific information available about the use of this medication in older adults, it’s important to approach any new treatment with caution. If you or a loved one is an older adult, be sure to discuss any potential risks or concerns with your healthcare provider. They can help determine the best approach for your individual health needs, especially since older adults may have different responses to medications compared to younger individuals. Always keep an open line of communication with your doctor about any changes in health or medication effects.

Renal Impairment

If you have kidney problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or safety considerations for your condition. This means that there are no tailored guidelines for how this medication may affect you or how it should be adjusted based on your kidney function.

Always consult your healthcare provider for personalized advice and to ensure that any medication you take is safe and appropriate for your health needs. They can help monitor your kidney function and make any necessary adjustments to your treatment plan.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication should be used if you have hepatic impairment (liver issues).

Always consult your healthcare provider for personalized advice and to ensure that any medication you take is safe and appropriate for your liver health. They can help you understand how to manage your treatment effectively.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. While there are no specific drug interactions or laboratory test interactions noted for this medication, your healthcare provider can help ensure that everything you are taking works well together and is safe for you. Always share your complete list of medications and any recent lab tests to avoid any potential issues. Your health and safety should always come first.

Storage and Handling

To ensure the safety and effectiveness of your product, store it at room temperature, away from direct sunlight and moisture. It's important to keep the product out of reach of children to prevent accidental ingestion or misuse. After each use, make sure to close the cap tightly to maintain its integrity. The product comes in child-resistant packaging, adding an extra layer of safety for households with young children. Always handle the product with care to ensure it remains safe for use.

Additional Information

You should apply a thin layer of the medication to the affected area every 6 to 8 hours, but do not exceed three applications in a 24-hour period. If you are pregnant or breastfeeding, it's important to consult a healthcare professional before using this product.

Make sure to keep the medication out of reach of children. If it is swallowed, seek medical help or contact a Poison Control Center right away.

FAQ

What is Gold Bond Maximum Strength Foot Pain Relief Cream used for?

It temporarily relieves minor pain.

How should I apply Gold Bond Maximum Strength Foot Pain Relief Cream?

Apply a thin layer to the affected area every 6 to 8 hours, not exceeding 3 applications in a 24-hour period. Massage it into the skin until thoroughly absorbed.

Can children use this cream?

Children under 12 years of age should ask a doctor before use.

What should I avoid while using this product?

Avoid contact with eyes and mucous membranes, do not bandage tightly, and do not use local heat or other topical analgesics at the same time.

Are there any contraindications for using this cream?

Do not use if you have serious foot problems, numbness, or on cut, irritated, or swollen skin.

What should I do if my condition worsens or irritation develops?

Stop use and ask a doctor if your condition worsens, redness is present, or symptoms persist for more than 7 days.

Is it safe to use this cream if I am pregnant or breastfeeding?

You should ask a health professional before using it if you are pregnant or breastfeeding.

What should I do if the cream is swallowed?

Get medical help or contact a Poison Control Center immediately.

How should I store Gold Bond Maximum Strength Foot Pain Relief Cream?

Store it at room temperature and keep it out of reach of children.

Packaging Info

Below are the non-prescription pack sizes of Gold Bond Maximum Strength Foot Pain Relief (lidocaine hydrochloride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Gold Bond Maximum Strength Foot Pain Relief.
Details

Drug Information (PDF)

This file contains official product information for Gold Bond Maximum Strength Foot Pain Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of minor pain. It is suitable for use in patients experiencing mild discomfort due to various conditions. Healthcare professionals should assess the appropriateness of this medication based on individual patient needs and circumstances.

Dosage and Administration

For adults and children over 12 years of age, a thin layer of the medication should be applied to the affected area every 6 to 8 hours. The total number of applications must not exceed 3 in a 24-hour period. It is important to massage the medication into the painful area until it is thoroughly absorbed into the skin.

For children under 12 years of age, it is recommended to consult a physician before use.

Contraindications

Use of this product is contraindicated in the following situations:

Patients with serious foot problems, including ulcers or infections, should not use this product due to the risk of exacerbating these conditions. Additionally, individuals with numbness or a reduced ability to feel pain are advised against use, as this may lead to unrecognized injury.

The product should not be applied to cut, irritated, or swollen skin, nor should it be used on puncture wounds, as these conditions may increase the risk of adverse effects. Furthermore, use for more than one week without consulting a healthcare professional is contraindicated to prevent potential complications.

Avoid contact with eyes and mucous membranes. Tight bandaging, local heat application (such as heating pads), or concurrent use with other topical analgesics is also contraindicated.

Warnings and Precautions

For external use only. This product is contraindicated in individuals with serious foot problems, including ulcers or infections. It should not be applied to areas with numbness or a reduced ability to feel pain, nor should it be used on cut, irritated, or swollen skin, or on puncture wounds. The product should not be used for more than one week without prior consultation with a healthcare professional.

Healthcare providers should advise patients to discontinue use and seek medical attention if any of the following occur: worsening of the condition, presence of redness, development of irritation, or if symptoms persist for more than seven days or resolve only to recur within a few days.

In the event of accidental ingestion, immediate medical assistance should be sought, or the individual should contact a Poison Control Center without delay.

Side Effects

Patients using this product should be aware of several important warnings and precautions. This product is intended for external use only and should not be applied if the patient has serious foot problems, such as ulcers or infections, or if there is numbness or a reduced ability to feel pain. It is contraindicated for use on cut, irritated, or swollen skin, as well as on puncture wounds. Additionally, patients should not use this product for more than one week without consulting a healthcare professional.

While using this product, it is crucial for patients to adhere strictly to the directions provided. They should avoid contact with the eyes and mucous membranes, and should not bandage the area tightly or apply local heat, such as heating pads or medicated patches, to the site of application. Concurrent use with other topical analgesics is also not recommended.

Patients are advised to discontinue use and consult a doctor if their condition worsens, if redness occurs, if irritation develops, or if symptoms persist for more than seven days or resolve and then recur within a few days.

For pregnant or breastfeeding individuals, it is recommended to seek advice from a healthcare professional prior to use. Furthermore, this product should be kept out of reach of children; in the event of ingestion, immediate medical assistance or contact with a Poison Control Center is necessary.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Gold Bond Maximum Strength Foot Pain Relief (lidocaine hydrochloride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Gold Bond Maximum Strength Foot Pain Relief.
Details

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. For adolescents and children aged 12 years and older, the recommended dosage is to apply a thin layer to the affected area every 6 to 8 hours, with a maximum of 3 applications within a 24-hour period. The product should be massaged into the painful area until fully absorbed into the skin.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to assess the potential risks and benefits associated with the use of this drug during pregnancy and lactation. Healthcare providers can offer guidance based on individual circumstances and the latest clinical data.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data on the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, it is imperative that immediate medical assistance is sought. Healthcare professionals should advise patients or caregivers to contact a Poison Control Center or seek medical help without delay if the substance is ingested.

Symptoms of overdosage may vary depending on the specific substance involved; however, it is crucial to monitor the patient closely for any adverse reactions. Prompt recognition of symptoms can facilitate timely intervention and improve patient outcomes.

Management of overdosage should be guided by the severity of symptoms and the specific circumstances surrounding the incident. Healthcare providers are encouraged to follow established protocols for the assessment and treatment of overdosage cases, which may include supportive care and symptomatic treatment as necessary.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to elucidate these aspects of nonclinical toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed not to use the product if they have serious foot problems, such as ulcers or infections, or if they experience numbness or a reduced ability to feel pain. It is important to emphasize that the product should not be applied to cut, irritated, or swollen skin, nor should it be used on puncture wounds.

Healthcare providers should counsel patients to limit the use of this product to no more than one week without consulting a doctor. Patients should be instructed to stop using the product and seek medical advice if their condition worsens, if redness is present, if irritation develops, or if symptoms persist for more than seven days or clear up and then recur within a few days.

When using this product, patients should be reminded to follow all directions and warnings on the carton carefully. They should avoid contact with eyes and mucous membranes. Additionally, patients should be advised not to bandage the area tightly, apply local heat (such as heating pads), or use a medicated patch on the area of application. It is also important to inform patients not to use this product simultaneously with other topical analgesics.

Storage and Handling

The product is supplied in child-resistant packaging to ensure safety and is designed to be stored at room temperature. It is essential to keep the product out of reach of children to prevent accidental ingestion. After each use, the cap should be closed tightly to maintain the integrity of the product.

Additional Clinical Information

The product is administered topically, with a recommended application of a thin layer to the affected area every 6 to 8 hours, not exceeding three applications within a 24-hour period. Clinicians should advise patients who are pregnant or breastfeeding to consult a health professional prior to use. Additionally, it is important to keep the product out of reach of children; if ingested, medical assistance or contact with a Poison Control Center is necessary.

No further information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Gold Bond Maximum Strength Foot Pain Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Gold Bond Maximum Strength Foot Pain Relief, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.